Mayne Pharma recalls

Mayne Pharma has 6 recalls on record with the FDA and USDA, the earliest in 2017 and the latest reported on 29 Jun 2022. 1 is still ongoing. The most frequent reason is potency & assay.

Total recalls6since 2017

Last 12 months0reported

Class I00% of total

Ongoing1latest 29 Jun 2022

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 4 67%Class III 2 33%

Why mayne pharma is recalled

Product types

Brands

Fabior117%
Clonidine117%

By year

2022233%
2020117%
2018233%
2017117%

Ongoing mayne pharma recalls

1 active

Reported	Class	Recall	Company	Reason	Where
26 Jan 2022Drug	CLASS II	Lexette (halobetasol propionate) Topical Foam, 05% canisters recalled	Mayne Pharma	Manufacturing (CGMP) Deviations	Nationwide

All mayne pharma recalls, newest first

6 total

Reported	Class	Recall	Company	Reason	Where
29 Jun 2022Drug	CLASS II	Clonidine Transdermal System, USP 3 mg/day, 4 Patches recalledClonidine	Mayne Pharma	Potency & Assay	Nationwide
26 Jan 2022Drug	CLASS II	Lexette (halobetasol propionate) Topical Foam, 05% canisters recalled	Mayne Pharma	Manufacturing (CGMP) Deviations	Nationwide
18 Mar 2020Drug	CLASS II	Carbidopa and Levodopa Tablets, USP 25 mg/250mg recalled by Mayne Pharma	Mayne Pharma	Packaging Defects	Nationwide
5 Sep 2018Drug	CLASS III	Oxycodone and Acetaminophen Tablets, USP, 5 mg*/325 mg recalled	Mayne Pharma	Labeling Errors	Nationwide
11 Apr 2018Drug	CLASS III	Fabior (tazarotene) Foam recalled by Mayne PharmaFabior	Mayne Pharma	Potency & Assay	Nationwide
6 Dec 2017Drug	CLASS II	Liothyronine Sodium Tablets, USP 25 mcg recalled by Mayne Pharma	Mayne Pharma	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.